Literature DB >> 15504981

Variation in NCB5OR: studies of relationships to type 2 diabetes, maturity-onset diabetes of the young, and gestational diabetes mellitus.

Gitte Andersen1, Lise Wegner, Christian Schack Rose, Jianxin Xie, Hao Zhu, Kevin Larade, Anders Johansen, Jakob Ek, Jeannet Lauenborg, Thomas Drivsholm, Knut Borch-Johnsen, Peter Damm, Torben Hansen, H Franklin Bunn, Oluf Pedersen.   

Abstract

Recent data show that homozygous Ncb5or(-/-) knock-out mice present with an early-onset nonautoimmune diabetes phenotype. Furthermore, genome-wide scans have reported linkage to the chromosome 6q14.2 region close to the human NCB5OR. We therefore considered NCB5OR to be a biological and positional candidate gene and examined the coding region of NCB5OR in 120 type 2 diabetic patients and 63 patients with maturity-onset diabetes of the young using denaturing high-performance liquid chromatography. We identified a total of 22 novel nucleotide variants. Three variants [IVS5+7del(CT), Gln187Arg, and His223Arg] were genotyped in a case-control design comprising 1,246 subjects (717 type 2 diabetic patients and 529 subjects with normal glucose tolerance). In addition, four rare variants were investigated for cosegregation with diabetes in multiplex type 2 diabetic families. The IVS5+7del(CT) variant was associated with common late-onset type 2 diabetes; however, we failed to relate this variant to any diabetes-related quantitative traits among the 529 control subjects. Thus, variation in the coding region of NCB5OR is not a major contributor in the pathogenesis of nonautoimmune diabetes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15504981      PMCID: PMC3044473          DOI: 10.2337/diabetes.53.11.2992

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  21 in total

1.  MODY in Iceland is associated with mutations in HNF-1alpha and a novel mutation in NeuroD1.

Authors:  S Y Kristinsson; E T Thorolfsdottir; B Talseth; E Steingrimsson; A V Thorsson; T Helgason; A B Hreidarsson; R Arngrimsson
Journal:  Diabetologia       Date:  2001-11       Impact factor: 10.122

2.  Identification of a cytochrome b-type NAD(P)H oxidoreductase ubiquitously expressed in human cells.

Authors:  H Zhu; H Qiu; H W Yoon; S Huang; H F Bunn
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

3.  Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice.

Authors:  M Pontoglio; S Sreenan; M Roe; W Pugh; D Ostrega; A Doyen; A J Pick; A Baldwin; G Velho; P Froguel; M Levisetti; S Bonner-Weir; G I Bell; M Yaniv; K S Polonsky
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

4.  Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus.

Authors:  M T Malecki; U S Jhala; A Antonellis; L Fields; A Doria; T Orban; M Saad; J H Warram; M Montminy; A S Krolewski
Journal:  Nat Genet       Date:  1999-11       Impact factor: 38.330

5.  High frequency of mutations in MODY and mitochondrial genes in Scandinavian patients with familial early-onset diabetes.

Authors:  M Lehto; C Wipemo; S A Ivarsson; C Lindgren; M Lipsanen-Nyman; J Weng; L Wibell; E Widén; T Tuomi; L Groop
Journal:  Diabetologia       Date:  1999-09       Impact factor: 10.122

6.  Increasing prevalence of diabetes mellitus and impaired glucose tolerance among 60-year-old Danes.

Authors:  T Drivsholm; H Ibsen; M Schroll; M Davidsen; K Borch-Johnsen
Journal:  Diabet Med       Date:  2001-02       Impact factor: 4.359

7.  Studies of the Ala/Val98 polymorphism of the hepatocyte nuclear factor-1alpha gene and the relationship to beta-cell function during an OGTT in glucose-tolerant women with and without previous gestational diabetes mellitus.

Authors:  J Lauenborg; P Damm; J Ek; C Glümer; T Jørgensen; K Borch-Johnsen; H Vestergaard; P Hornnes; O Pedersen; T Hansen
Journal:  Diabet Med       Date:  2004-12       Impact factor: 4.359

8.  Diabetic family history is an isolated risk factor for gestational diabetes after 30 years of age.

Authors:  Louis Yik-Si Chan; Shell Fean Wong; Lau Cheung Ho
Journal:  Acta Obstet Gynecol Scand       Date:  2002-02       Impact factor: 3.636

9.  Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY.

Authors:  Y Horikawa; N Iwasaki; M Hara; H Furuta; Y Hinokio; B N Cockburn; T Lindner; K Yamagata; M Ogata; O Tomonaga; H Kuroki; T Kasahara; Y Iwamoto; G I Bell
Journal:  Nat Genet       Date:  1997-12       Impact factor: 38.330

10.  The Ala/Val98 polymorphism of the hepatocyte nuclear factor-1alpha gene contributes to the interindividual variation in serum C-peptide response during an oral glucose tolerance test: evidence from studies of 231 glucose-tolerant first degree relatives of type 2 diabetic probands.

Authors:  S A Urhammer; T Hansen; C T Ekstrøm; H Eiberg; O Pedersen
Journal:  J Clin Endocrinol Metab       Date:  1998-12       Impact factor: 5.958

View more
  4 in total

Review 1.  Advancing animal models of human type 1 diabetes by engraftment of functional human tissues in immunodeficient mice.

Authors:  Michael A Brehm; Alvin C Powers; Leonard D Shultz; Dale L Greiner
Journal:  Cold Spring Harb Perspect Med       Date:  2012-05       Impact factor: 6.915

2.  Ncb5or deficiency increases fatty acid catabolism and oxidative stress.

Authors:  Ming Xu; WenFang Wang; Jennifer R Frontera; Melanie C Neely; Jianghua Lu; Daniel Aires; Fong-Fu Hsu; John Turk; Russell H Swerdlow; Susan E Carlson; Hao Zhu
Journal:  J Biol Chem       Date:  2011-02-07       Impact factor: 5.157

Review 3.  Common defects of mitochondria and iron in neurodegeneration and diabetes (MIND): a paradigm worth exploring.

Authors:  Matthew Stroh; Russell H Swerdlow; Hao Zhu
Journal:  Biochem Pharmacol       Date:  2013-12-19       Impact factor: 5.858

4.  Loss of NCB5OR in the cerebellum disturbs iron pathways, potentiates behavioral abnormalities, and exacerbates harmaline-induced tremor in mice.

Authors:  Matthew A Stroh; Michelle K Winter; Russell H Swerdlow; Kenneth E McCarson; Hao Zhu
Journal:  Metab Brain Dis       Date:  2016-05-18       Impact factor: 3.584

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.